These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3324561)

  • 61. [Contragestion].
    Couzinet B; Schaison G
    Rev Prat; 1987 Sep; 37(38):2285-92. PubMed ID: 3659795
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effects of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg dienogest on thyroid hormones and androgen parameters: conventional vs. extended-cycle use.
    Sänger N; Stahlberg S; Manthey T; Mittmann K; Mellinger U; Lange E; Kuhl H; Wiegratz I
    Contraception; 2008 Jun; 77(6):420-5. PubMed ID: 18477491
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Statement on postcoital contraception.
    International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
    IPPF Med Bull; 1981 Dec; 15(6):5-6. PubMed ID: 12263975
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Ethinylestradiol + etonogestrel contraceptive vaginal ring: new drug. Possibly useful in some situations.
    Prescrire Int; 2006 Apr; 15(82):50-3. PubMed ID: 16604729
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Estradiol valerate/dienogest: in oral contraception.
    Hoy SM; Scott LJ
    Drugs; 2009 Aug; 69(12):1635-46. PubMed ID: 19678714
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Emergency contraception: lack of awareness among patients presenting for pregnancy termination.
    Jamieson MA; Hertweck SP; Sanfilippo JS
    J Pediatr Adolesc Gynecol; 1999 Feb; 12(1):11-5. PubMed ID: 9929834
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Interception by post-coital IUD insertion.
    Van Santen MR; Haspels AA
    Contracept Deliv Syst; 1981 Jul; 2(3):189-200. PubMed ID: 12278905
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Efficacy and bleeding profile of a combined oral contraceptive containing oestradiol valerate/dienogest: a pooled analysis of three studies conducted in North America and Europe.
    Nelson A; Parke S; Makalova D; Serrani M; Palacios S; Mellinger U
    Eur J Contracept Reprod Health Care; 2013 Aug; 18(4):264-73. PubMed ID: 23651474
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pharmacokinetics of the progestin dienogest (STS 557) in rabbits.
    Hillesheim HG; Ritter P; Valentin U; Hobe G
    Exp Clin Endocrinol; 1989 Sep; 94(1-2):194-202. PubMed ID: 2599018
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pharmacokinetic study of single and multiple oral administrations of 2 mg dienogest in healthy Korean women.
    Shin D; Lee S; Lim KS; Park JS; Shin SG; Jang IJ; Yu KS
    Contraception; 2013 Jun; 87(6):750-5. PubMed ID: 23218856
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Dienogest.
    Foster RH; Wilde MI
    Drugs; 1998 Nov; 56(5):825-33; discussion 834-5. PubMed ID: 9829156
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Lipid metabolism during treatment of endometriosis with the progestin dienogest.
    Köhler G; Göretzlehner G; Brachmann K
    Acta Obstet Gynecol Scand; 1989; 68(7):633-5. PubMed ID: 2631529
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [The significance of post-coital hormonal contraception for prevention of conception].
    Köhler G
    Z Arztl Fortbild (Jena); 1990; 84(1-2):21-4. PubMed ID: 2184592
    [No Abstract]   [Full Text] [Related]  

  • 75. [Synthesis of 4-substituted 17 beta-hydroxy-7 alpha-methyl-4-estren-3-one and their 17-acetates as antifertility compounds].
    Ma JB; Li ZS
    Yao Xue Xue Bao; 1990; 25(1):18-23. PubMed ID: 2363352
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Postcoital contraception: myth or reality?
    Silvestre L; Bouali Y; Ulmann A
    Lancet; 1991 Jul; 338(8758):39-41. PubMed ID: 1676094
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Efficacy of dienogest in the treatment of symptomatic adenomyosis: a pilot study.
    Hirata T; Izumi G; Takamura M; Saito A; Nakazawa A; Harada M; Hirota Y; Koga K; Fujii T; Osuga Y
    Gynecol Endocrinol; 2014 Oct; 30(10):726-9. PubMed ID: 24905725
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Relief of uterine bleeding by cyclic administration of dienogest for endometriosis.
    Yanase T; Tsuneki I; Tamura M; Kurabayashi T
    Gynecol Endocrinol; 2014 Nov; 30(11):804-7. PubMed ID: 25060125
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [The risk of an unwanted pregnancy following one unprotected coitus; observation concerning the current hormonal postcoital contraceptive methods].
    Oddens BJ
    Ned Tijdschr Geneeskd; 1992 Dec; 136(50):2483-4. PubMed ID: 1465173
    [No Abstract]   [Full Text] [Related]  

  • 80. Effect and safety of high-dose dienogest (20 mg/day) in the treatment of women with endometriosis.
    Schindler AE; Henkel A; Moore C; Oettel M
    Arch Gynecol Obstet; 2010 Nov; 282(5):507-14. PubMed ID: 20012981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.